STEPHANIE ARNOLD: Open Payments
NPI 1508159096 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 39 payments from 14 companies in 2025. Trend: 2023 $5,582 · 2024 $4,240 · 2025 $2,415
Food & beverage: $1,404Travel & lodging: $968Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $1,391 |
| Insulet Corporation | 5 | $218 |
| Sequel Med Tech, LLC | 2 | $215 |
| BETA BIONICS, INC. | 1 | $125 |
| Tandem Diabetes Care, Inc. | 1 | $112 |
| Medtronic, Inc. | 2 | $100 |
| Mannkind Corporation | 3 | $86 |
| ABBVIE INC. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
Products named: Ozempic, Omnipod, TWIIST, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, AFREZZA, Rybelsus.
Industry payments across IN — which companies pay providers there.
